Transformative Detection is the fastest growing segment fueling the growth of Southern Blotting Market
Market Overview:
Southern blotting is a technique used to detect a specific DNA or RNA sequence
in a sample using a DNA or RNA probe. The Southern blotting technique ias used
by scientists to identify gene mutations and diagnose genetic disorders. It
enables the detection of gene mutations that cannot be identified using other
methods.
The global
Southern Blotting Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
One of the major trends in the Southern blotting market is the increased adoption
of advanced technologies like chemiluminescent and colorimetric detection
systems. These new detection systems offer enhanced sensitivity and faster
detection of DNA and RNA targets as compared to conventional chromogenic
substrates. They have significantly improved the efficiency and reliability of
Southern blotting experiments. Furthermore, the availability of reagents, kits
and systems tailored for specific applications like microRNA detection has
boosted the popularity of Southern blotting technique among researchers.
Segment Analysis
The southern blotting market can be segmented into consumables, instruments,
and services. The consumables segment dominated the market in 2022, accounting
for over 50% share. The segment is expected to continue its dominance during
the forecast period. The high and regular demand for probes, substrate
chemicals, film, and membranes drives the consumables segment.
Key Takeaways
The global Southern
Blotting Market Growth is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period,
due to increasing research activities in genomics and proteomics.
Regional analysis
North America dominated the global southern blotting market in 2022 and is
expected to continue its dominance during the forecast period. This is
attributed to presence of major market players and stringent regulations
regarding genomic research in countries like US and Canada. Asia Pacific is
expected to be the fastest growing regional market during the forecast period,
driven by increasing research funding and growing population.
Key players
Key players operating in the southern blotting market are Thermo Fisher
Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, PerkinElmer,
GE Healthcare, Promega Corporation, Genetec, and Bio-Rad Laboratories. Thermo
Fisher Scientific and Merck KGaA dominate the consumables segment, whereas
Agilent Technologies and Bio-Rad Laboratories hold a significant share in the
instruments segment.
Comments
Post a Comment